Table 1.
Demographics and clinicopathological features of the patients
| Basic demographics of the patients | ||
|---|---|---|
| Gender | ||
| Male | 77 (74.8%) | |
| Female | 26 (25.2%) | |
| Age distribution | ||
| 11–25 | 9 (8.7%) | |
| 26–40 | 45 (43.7%) | |
| 41–55 | 31 (30.1%) | |
| 56–70 | 18 (17.5%) | |
| Clinicopathological feature | Patients positive for CD1a clone MTB1 n (%) | Patients negative for CD1a clone MTB1 n (%) |
| Granuloma formation | ||
| Poor-formed granuloma | 43 (58.9%) | 18 (60%) |
| Well-formed granuloma | 30 (41.1%) | 12 (40%) |
| Intensity of the inflammation | ||
| Superficial inflammation | 25 (34.2%) | 15 (50%) |
| Whole dermis inflammation | 48 (65.8%) | 15 (50%) |
| Lesion type | ||
| Papules & nodules | 45 (61.6%) | 14 (46.7%) |
| Ulcers & scars | 28 (38.4%) | 16 (53.3%) |
| Duration of the lesion | ||
| Less than 3 months | 41 (56.2%) | 15 (50%) |
| More than 3 months | 32 (43.8%) | 15 (50%) |